v3.25.0.1
Collaborations (Tables)
 12 Months Ended
Dec. 31, 2024
Janssen Biotech, Inc  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Janssen and AbbVie:
years ended December 31 (in millions)202420232022
United States - Janssen's share of profits (included in cost of products sold)$1,140 $1,245 $1,607 
International - AbbVie's share of profits (included in net revenues)899 931 1,142 
Global - AbbVie's share of other costs (included in respective line items)162 228 268 
Genentech, Inc.  
Collaborative Arrangements and Non-collaborative Arrangement Transactions  
Schedule of profit and cost sharing relationship
The following table shows the profit and cost sharing relationship between Genentech and AbbVie:
years ended December 31 (in millions)202420232022
Genentech's share of profits, including royalties (included in cost of products sold)$990 $869 $778 
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)29 41 37 
AbbVie's share of development costs (included in R&D)84 109 121